Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial.

Whittaker Brown SA, Padilla M, Mhango G, Powell C, Salvatore M, Henschke C, Yankelevitz D, Sigel K, de-Torres JP, Wisnivesky J.

Chest. 2019 Aug 9. pii: S0012-3692(19)31448-5. doi: 10.1016/j.chest.2019.06.041. [Epub ahead of print]

PMID:
31404527
2.

B Cell Adaptive Immune Profile in Emphysema-Predominant COPD.

Sullivan JL, Bagevalu B, Glass C, Sholl L, Kraft M, Martinez FD, Bastarrika G, de-Torres JP, San José Estépar R, Guerra S, Polverino F.

Am J Respir Crit Care Med. 2019 Jul 26. doi: 10.1164/rccm.201903-0632LE. [Epub ahead of print] No abstract available.

PMID:
31348682
3.

Emphysema phenotypes and lung cancer risk.

González J, Henschke CI, Yankelevitz DF, Seijo LM, Reeves AP, Yip R, Xie Y, Chung M, Sánchez-Salcedo P, Alcaide AB, Campo A, Bertó J, Del Mar Ocón M, Pueyo J, Bastarrika G, de-Torres JP, Zulueta JJ.

PLoS One. 2019 Jul 25;14(7):e0219187. doi: 10.1371/journal.pone.0219187. eCollection 2019.

4.

External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study.

Almagro P, Martínez-Camblor P, Miravitlles M, Rodríguez-Carballeira M, Navarro A, Lamprecht B, Ramirez-Garcia Luna AS, Kaiser B, Alfageme I, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Celli BR, Marin JM, Ter Riet G, Sobradillo P, Lange P, Garcia-Aymerich J, Anto JM, Turner AM, Han MK, Langhammer A, Sternberg A, Leivseth L, Bakke P, Johannessen A, Oga T, Cosío B, Ancochea J, Echazarreta A, Roche N, Burgel PR, Sin DD, Puhan MA, Soriano JB; 3CIA collaboration.

COPD. 2019 Feb;16(1):8-17. doi: 10.1080/15412555.2018.1484440. Epub 2019 Mar 14.

PMID:
30870059
5.

The Global Burden of Pulmonary Diseases: Most Prevalent Problems and Opportunities for Improvement.

Wisnivesky J, De-Torres JP.

Ann Glob Health. 2019 Jan 22;85(1). pii: 1. doi: 10.5334/aogh.2411.

PMID:
30741502
6.

The effect of radiographic emphysema in assessing lung cancer risk.

Yong PC, Sigel K, de-Torres JP, Mhango G, Kale M, Kong CY, Zulueta JJ, Wilson D, Brown SW, Slatore C, Wisnivesky J.

Thorax. 2019 Sep;74(9):858-864. doi: 10.1136/thoraxjnl-2018-212457. Epub 2019 Feb 5.

PMID:
30723183
7.

Prognostic Validation Using GesEPOC 2017 Severity Criteria.

Cabrera López C, Casanova Macario C, Marín Trigo JM, de-Torres JP, Torres RS, González JM, Polverino F, Divo M, Pinto Plata V, Zulueta J, Callejas FJ, Celli B.

Arch Bronconeumol. 2019 Aug;55(8):409-413. doi: 10.1016/j.arbres.2018.12.002. Epub 2019 Feb 2. English, Spanish.

8.

Trabecular bone score in active or former smokers with and without COPD.

González J, Rodríguez-Fraile M, Rivera P, Restituto P, Colina I, Calleja MLD, Alcaide AB, Campo A, Bertó J, Seijo LM, Pérez T, Zulueta J, Varo N, de-Torres JP.

PLoS One. 2019 Feb 1;14(2):e0209777. doi: 10.1371/journal.pone.0209777. eCollection 2019.

9.

The Prevalence of Obstructive Lung Disease in a Lung Cancer Screening Cohort: Analysis of the National Lung Screening Trial-American College of Radiology Image Network Cohort.

de-Torres JP, Wisnivesky JP, Bastarrika G, Wilson DO, Celli BR, Zulueta JJ.

Ann Am Thorac Soc. 2019 May;16(5):641-644. doi: 10.1513/AnnalsATS.201811-817RL. No abstract available.

PMID:
30673510
10.

Radiologic features of small pulmonary nodules detected in initially negative screening CT examinations: a step towards personalized screening strategies?

Bastarrika G, de-Torres JP, Zulueta JJ.

Ann Transl Med. 2018 Nov;6(Suppl 1):S51. doi: 10.21037/atm.2018.10.14. No abstract available.

11.

5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.

Martínez-Terroba E, Behrens C, Agorreta J, Monsó E, Millares L, Felip E, Rosell R, Ramirez JL, Remirez A, Torre W, Gil-Bazo I, Idoate MA, de-Torres JP, Pio R, Wistuba II, Pajares MJ, Montuenga LM.

Thorax. 2019 Apr;74(4):371-379. doi: 10.1136/thoraxjnl-2018-212194. Epub 2018 Nov 24.

PMID:
30472670
12.

Temporal transitions in COPD severity stages within the GOLD 2017 classification system.

Soriano JB, Hahsler M, Soriano C, Martinez C, de-Torres JP, Marín JM, de Lucas P, Cosio BG, Fuster A, Casanova C; CHAIN investigators.

Respir Med. 2018 Sep;142:81-85. doi: 10.1016/j.rmed.2018.07.019. Epub 2018 Aug 3.

PMID:
30170807
13.

Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer.

Fusco JP, Pita G, Pajares MJ, Andueza MP, Patiño-García A, de-Torres JP, Gurpide A, Zulueta J, Alonso R, Alvarez N, Pio R, Melero I, Sanmamed MF, Rodriguez Ruiz M, Gil-Bazo I, Lopez-Picazo JM, Casanova C, Baz Davila R, Agudo A, Lozano MD, Gonzalez A, Sala N, Ardanaz E, Benitez J, Montuenga L, Gonzalez-Neira A, Perez-Gracia JL.

Cancer Med. 2018 May 15. doi: 10.1002/cam4.1500. [Epub ahead of print]

14.

Pulmonary arterial enlargement predicts long-term survival in COPD patients.

de-Torres JP, Ezponda A, Alcaide AB, Campo A, Berto J, Gonzalez J, Zulueta JJ, Casanova C, Rodriguez-Delgado LE, Celli BR, Bastarrika G.

PLoS One. 2018 Apr 25;13(4):e0195640. doi: 10.1371/journal.pone.0195640. eCollection 2018.

15.

Gas exchange and breathing pattern in women with postmenopausal bone fragility.

Polverino F, de Torres JP, Santoriello C, Capuozzo A, Mauro I, Rojas-Quintero J, D'Agostino B, Pistolesi M, Celli B, Polverino M, Owen CA.

Respir Med. 2018 Apr;137:141-146. doi: 10.1016/j.rmed.2018.03.006. Epub 2018 Mar 7.

PMID:
29605198
16.

Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease.

Guerra B, Haile SR, Lamprecht B, Ramírez AS, Martinez-Camblor P, Kaiser B, Alfageme I, Almagro P, Casanova C, Esteban-González C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Marin JM, Ter Riet G, Sobradillo P, Lange P, Garcia-Aymerich J, Antó JM, Turner AM, Han MK, Langhammer A, Leivseth L, Bakke P, Johannessen A, Oga T, Cosio B, Ancochea-Bermúdez J, Echazarreta A, Roche N, Burgel PR, Sin DD, Soriano JB, Puhan MA; 3CIA collaboration.

BMC Med. 2018 Mar 2;16(1):33. doi: 10.1186/s12916-018-1013-y.

17.

Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort.

Martínez-González C, Casanova C, de-Torres JP, Marín JM, de Lucas P, Fuster A, Cosío BG, Calle M, Peces-Barba G, Solanes I, Agüero R, Feu-Collado N, Alfageme I, Romero Plaza A, Balcells E, de Diego A, Marín Royo M, Moreno A, Llunell Casanovas A, Galdiz JB, Golpe R, Lacárcel Bautista C, Cabrera C, Marin A, Soriano JB, Lopez-Campos JL; CHAIN Study Investigators.

Chest. 2018 Aug;154(2):274-285. doi: 10.1016/j.chest.2018.02.007. Epub 2018 Feb 22.

PMID:
29476876
18.

Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort.

Divo MJ, Celli BR, Poblador-Plou B, Calderón-Larrañaga A, de-Torres JP, Gimeno-Feliu LA, Bertó J, Zulueta JJ, Casanova C, Pinto-Plata VM, Cabrera-Lopez C, Polverino F, Carmona Píréz J, Prados-Torres A, Marin JM; EpiChron—BODE Collaborative Group.

PLoS One. 2018 Feb 22;13(2):e0193143. doi: 10.1371/journal.pone.0193143. eCollection 2018.

19.

Acute pericarditis following second-generation cryoballoon ablation for atrial fibrillation.

Mugnai G, de Asmundis C, Iacopino S, Ströker E, Longobardi M, Negro MC, De Regibus V, Coutino-Moreno HE, Takarada K, Choudhury R, de Torres JPA, Storti C, Brugada P, Chierchia GB.

J Interv Card Electrophysiol. 2018 Apr;51(3):279-284. doi: 10.1007/s10840-018-0329-z. Epub 2018 Feb 14.

PMID:
29445985
20.

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim YI, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee SD, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O'Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003. Review.

21.

Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD.

Casanova C, Celli BR, de-Torres JP, Martínez-Gonzalez C, Cosio BG, Pinto-Plata V, de Lucas-Ramos P, Divo M, Fuster A, Peces-Barba G, Calle-Rubio M, Solanes I, Aguero R, Feu-Collado N, Alfageme I, De Diego A, Romero A, Balcells E, Llunell A, Galdiz JB, Marin M, Moreno A, Cabrera C, Golpe R, Lacarcel C, Soriano JB, López-Campos JL, Soler-Cataluña JJ, Marin JM.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701162. doi: 10.1183/13993003.01162-2017. Print 2017 Nov.

22.

Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on Grouping and Outcomes.

Cabrera López C, Casanova Macario C, Marín Trigo JM, de-Torres JP, Sicilia Torres R, González JM, Polverino F, Divo M, Pinto Plata V, Zulueta JJ, Celli B.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):463-469. doi: 10.1164/rccm.201707-1363OC.

PMID:
29099607
23.

A simple algorithm for the identification of clinical COPD phenotypes.

Burgel PR, Paillasseur JL, Janssens W, Piquet J, Ter Riet G, Garcia-Aymerich J, Cosio B, Bakke P, Puhan MA, Langhammer A, Alfageme I, Almagro P, Ancochea J, Celli BR, Casanova C, de-Torres JP, Decramer M, Echazarreta A, Esteban C, Gomez Punter RM, Han MK, Johannessen A, Kaiser B, Lamprecht B, Lange P, Leivseth L, Marin JM, Martin F, Martinez-Camblor P, Miravitlles M, Oga T, Sofia Ramírez A, Sin DD, Sobradillo P, Soler-Cataluña JJ, Turner AM, Verdu Rivera FJ, Soriano JB, Roche N; Initiatives BPCO, EABPCO, Leuven and 3CIA study groups.

Eur Respir J. 2017 Nov 2;50(5). pii: 1701034. doi: 10.1183/13993003.01034-2017. Print 2017 Nov.

24.

The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study.

de Torres JP, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Cosio B, Casanova C; COPD History Assessment In SpaiN (CHAIN) cohort.

Respirology. 2018 May;23(5):485-491. doi: 10.1111/resp.13194. Epub 2017 Oct 12.

PMID:
29027309
25.

Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients.

Zagaceta J, Bastarrika G, Zulueta JJ, Colina I, Alcaide AB, Campo A, Divo M, Casanova C, Marin JM, Pinto-Plata VM, Celli BR, de-Torres JP.

Respir Res. 2017 Sep 29;18(1):175. doi: 10.1186/s12931-017-0658-y.

26.

Erratum to: Telomere shortening and accelerated aging in COPD: findings from the BODE cohort.

Cordoba-Lanus E, Cazorla-Rivero S, Espinoza-Jimenez A, de-Torres JP, Pajares MJ, Aguirre-Jaime A, Celli B, Casanova C.

Respir Res. 2017 Jun 2;18(1):113. doi: 10.1186/s12931-017-0589-7. No abstract available.

27.

Differences between GesEPOC and GOLD in 2017.

de-Torres JP, Marin JM.

Arch Bronconeumol. 2017 Jun;53(6):295-296. doi: 10.1016/j.arbres.2017.04.005. Epub 2017 May 13. English, Spanish. No abstract available.

28.

Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease.

Riesco Miranda JA, Alcázar B, Alfageme I, Casanova C, Celli B, de-Torres JP, Jiménez Ruiz CA.

Arch Bronconeumol. 2017 Oct;53(10):574-582. doi: 10.1016/j.arbres.2017.03.022. Epub 2017 May 9. Review. English, Spanish.

29.

Telomere shortening and accelerated aging in COPD: findings from the BODE cohort.

Córdoba-Lanús E, Cazorla-Rivero S, Espinoza-Jiménez A, de-Torres JP, Pajares MJ, Aguirre-Jaime A, Celli B, Casanova C.

Respir Res. 2017 Apr 13;18(1):59. doi: 10.1186/s12931-017-0547-4. Erratum in: Respir Res. 2017 Jun 2;18(1):113.

30.

Chronic obstructive pulmonary disease in Women. Is it Different?

Alonso T, Sobradillo P, de Torres JP.

Arch Bronconeumol. 2017 Apr;53(4):222-227. doi: 10.1016/j.arbres.2016.10.008. Epub 2017 Feb 3. Review. English, Spanish. No abstract available.

31.

Telomere length, COPD and emphysema as risk factors for lung cancer.

de-Torres JP, Sanchez-Salcedo P, Bastarrika G, Alcaide AB, Pío R, Pajares MJ, Campo A, Berto J, Montuenga L, Del Mar Ocon M, Monente C, Celli BR, Zulueta JJ.

Eur Respir J. 2017 Jan 3;49(1). pii: 1601521. doi: 10.1183/13993003.01521-2016. Print 2017 Jan. No abstract available.

32.

Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation.

Alcaide AB, Sanchez-Salcedo P, Bastarrika G, Campo A, Berto J, Ocon MD, Fernandez-Montero A, Celli BR, Zulueta JJ, de-Torres JP.

Chest. 2017 Feb;151(2):358-365. doi: 10.1016/j.chest.2016.10.044. Epub 2016 Nov 3.

PMID:
27818328
33.

Is Chronic Obstructive Pulmonary Disease Really a Progressive Disease?

de Torres JP, Celli BR.

Arch Bronconeumol. 2017 Jul;53(7):362-363. doi: 10.1016/j.arbres.2016.08.005. Epub 2016 Oct 17. Review. English, Spanish. No abstract available.

34.

Distribution and Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort.

Cosio BG, Soriano JB, López-Campos JL, Calle M, Soler JJ, de-Torres JP, Marín JM, Martínez C, de Lucas P, Mir I, Peces-Barba G, Feu-Collado N, Solanes I, Alfageme I; CHAIN study.

PLoS One. 2016 Sep 29;11(9):e0160770. doi: 10.1371/journal.pone.0160770. eCollection 2016. Erratum in: PLoS One. 2016 Nov 2;11(11):e0166257.

35.

Lung Cancer and Emphysema.

Gonzalez J, de-Torres JP.

Arch Bronconeumol. 2017 Feb;53(2):47-48. doi: 10.1016/j.arbres.2016.07.010. Epub 2016 Aug 25. English, Spanish. No abstract available.

36.

Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study.

Cabrera C, Casanova C, Martín Y, Mirabal V, Sánchez Mdel C, Álvarez F, Juliá G, Cabrera-Navarro P, García-Bello MÁ, Marín JM, de-Torres JP, Divo M, Celli B.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 8;11:1217-22. doi: 10.2147/COPD.S100853. eCollection 2016.

37.

Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.

Garcia-Velloso MJ, Bastarrika G, de-Torres JP, Lozano MD, Sanchez-Salcedo P, Sancho L, Nuñez-Cordoba JM, Campo A, Alcaide AB, Torre W, Richter JA, Zulueta JJ.

Lung Cancer. 2016 Jul;97:81-6. doi: 10.1016/j.lungcan.2016.04.025. Epub 2016 May 2.

PMID:
27237032
38.

The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development.

Sanchez-Salcedo P, de-Torres JP, Martinez-Urbistondo D, Gonzalez-Gutierrez J, Berto J, Campo A, Alcaide AB, Zulueta JJ.

Lung Cancer. 2016 Jul;97:28-34. doi: 10.1016/j.lungcan.2016.04.010. Epub 2016 Apr 16.

PMID:
27237024
39.

Prognostic assessment in COPD without lung function: the B-AE-D indices.

Boeck L, Soriano JB, Brusse-Keizer M, Blasi F, Kostikas K, Boersma W, Milenkovic B, Louis R, Lacoma A, Djamin R, Aerts J, Torres A, Rohde G, Welte T, Martinez-Camblor P, Rakic J, Scherr A, Koller M, van der Palen J, Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Tamm M, Stolz D.

Eur Respir J. 2016 Jun;47(6):1635-44. doi: 10.1183/13993003.01485-2015. Epub 2016 Apr 21.

40.

Is COPD a Progressive Disease? A Long Term Bode Cohort Observation.

de-Torres JP, Marín JM, Pinto-Plata V, Divo M, Sanchez-Salcedo P, Zagaceta J, Zulueta JJ, Berto J, Cabrera C, Celli BR, Casanova C.

PLoS One. 2016 Apr 21;11(4):e0151856. doi: 10.1371/journal.pone.0151856. eCollection 2016.

41.

Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?

Polverino F, Laucho-Contreras M, Rojas Quintero J, Divo M, Pinto-Plata V, Sholl L, de-Torres JP, Celli BR, Owen CA.

Multidiscip Respir Med. 2016 Apr 4;11:17. doi: 10.1186/s40248-016-0051-6. eCollection 2016.

42.

Simplifying the guidelines: The 10 COPD commandments.

Marin JM, Cote C, Casanova C, Pinto-Plata V, Montes de Oca M, Divo MJ, de Torres JP, Zulueta J, Cabrera C, Carrizo S, Polverino F, Celli BR; En Representación del Grupo BODE.

Arch Bronconeumol. 2016 Apr;52(4):179-80. doi: 10.1016/j.arbres.2016.01.012. Epub 2016 Mar 10. English, Spanish. No abstract available.

43.

Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.

de-Torres JP, Marín JM, Casanova C, Pinto-Plata V, Divo M, Cote C, Celli BR, Zulueta JJ.

Chest. 2016 Apr;149(4):936-42. doi: 10.1378/chest.15-1868. Epub 2016 Jan 12.

PMID:
26513409
44.

Genome Expression Profiling-Based Identification and Administration Efficacy of Host-Directed Antimicrobial Drugs against Respiratory Infection by Nontypeable Haemophilus influenzae.

Euba B, Moleres J, Segura V, Viadas C, Morey P, Moranta D, Leiva J, de-Torres JP, Bengoechea JA, Garmendia J.

Antimicrob Agents Chemother. 2015 Dec;59(12):7581-92. doi: 10.1128/AAC.01278-15. Epub 2015 Sep 28.

45.

Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort.

Cosio BG, Soriano JB, López-Campos JL, Calle-Rubio M, Soler-Cataluna JJ, de-Torres JP, Marín JM, Martínez-Gonzalez C, de Lucas P, Mir I, Peces-Barba G, Feu-Collado N, Solanes I, Alfageme I, Casanova C; CHAIN Study.

Chest. 2016 Jan;149(1):45-52. doi: 10.1378/chest.15-1055. Epub 2016 Jan 6.

PMID:
26291753
46.

What pulmonologists think about the asthma-COPD overlap syndrome.

Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 15;10:1321-30. doi: 10.2147/COPD.S88667. eCollection 2015.

47.

COPD comorbidities network.

Divo MJ, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta JJ, Cabrera C, Zagaceta J, Sanchez-Salcedo P, Berto J, Davila RB, Alcaide AB, Cote C, Celli BR; BODE Collaborative Group.

Eur Respir J. 2015 Sep;46(3):640-50. doi: 10.1183/09031936.00171614. Epub 2015 Jul 9.

48.

Immunomodulating effects of glatiramer acetate and its potential role in pulmonary tuberculosis reactivation.

Sánchez-Salcedo P, de-Torres JP.

Arch Bronconeumol. 2015 Dec;51(12):656-7. doi: 10.1016/j.arbres.2015.03.016. Epub 2015 Jun 3. English, Spanish. No abstract available.

49.

Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.

Soriano JB, Lamprecht B, Ramírez AS, Martinez-Camblor P, Kaiser B, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Marin JM, Puhan MA, Sobradillo P, Lange P, Sternberg AL, Garcia-Aymerich J, Turner AM, Han MK, Langhammer A, Leivseth L, Bakke P, Johannessen A, Roche N, Sin DD.

Lancet Respir Med. 2015 Jun;3(6):443-50. doi: 10.1016/S2213-2600(15)00157-5. Epub 2015 May 17.

PMID:
25995071
50.

Lung Cancer Screening: The Balance between Harm and Benefit.

Zulueta JJ, de-Torres JP.

Am J Respir Crit Care Med. 2015 May 15;191(10):1209. doi: 10.1164/rccm.201502-0345LE. No abstract available.

PMID:
25978578

Supplemental Content

Loading ...
Support Center